IFx-Hu2.0 not checked

TuHURA Biosciences, Inc. · pAc/emm55

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
2 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Therapeutic Classification: • Innate immune agonist Route of Administration: • Intralesional”In the company’s words, NCT06947928 on ClinicalTrials.gov
Tested for
Advanced Or Metastatic Merkel Cell Carcinoma (2 trials)
Main trialPhase 2/3
“This Phase 2/3, multicenter, randomized, double-blind, placebo-controlled trial will evaluate the Objective Response Rate (ORR) of IFx-Hu2.0 as an adjunctive therapy to pembrolizumab in adult participants (≥18 years) with advanced or metastatic Merkel Cell Carcinoma. A total of 118 participants will be randomized to receive either IFx-Hu2.0 or placebo via intralesional injection in a single lesion, followed by pembrolizumab.”In the company’s words, NCT06947928 on ClinicalTrials.gov
Other names
pAc/emm55

Other drugs for Advanced Or Metastatic Merkel Cell Carcinoma

All 302 drugs for Advanced Or Metastatic Merkel Cell Carcinoma

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 2/3Recruiting 31 Mar 2027 Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Phase 1Recruiting Apr 2027 IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)
Phase 1Completed 7 Oct 2021 IFx-Hu2.0 for the Treatment of Patients With Skin Cancer
Phase 1Completed 19 Oct 2023 Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow IFx-Hu2.0

Following is part of Solo: you see every change to IFx-Hu2.0 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in